Press Releases

Decision Resources Releases Quarterly Treatment Algorithms Insight Series Update

Decision Resources’ Examination of U.S. Patient-Level Claims Data Reveals Insights into Disease-Specific Drug Usage By Line of Therapy

BURLINGTON, Mass.--(BUSINESS WIRE)-- Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, has released the third installment of its 2012 Treatment Algorithms Insight Series, which examines U.S. physicians’ prescribing behavior, going beyond estimates of overall patient share to provide a quantitative analysis of an agent’s penetration into each line of therapy for a specific disease. Updated quarterly, the Treatment Algorithms Insight Series is supported by a deep longitudinal patient-level claims dataset, which includes Medicare supplemental and commercially insured patients.

“The Treatment Algorithms Insight Series is a valuable tool for pharmaceutical marketers looking to understand treatment dynamics, without having to rely on physician recall,” said Director Nicole Westphal, Ph.D. “This year, we’ve expanded our coverage to also assess drug compliance. The full Treatment Algorithms analysis will help marketers understand trends in drug utilization by disease, and how prescribing patterns change following new market launches and recent generic entry events.”

Decision Resources covers the following diseases as part of the Treatment Algorithms service:

-- Alzheimer’s Disease            
-- Asthma
-- Bipolar Disorder
-- Crohn’s Disease
-- Chronic Obstructive Pulmonary Disease
-- Dyslipidemia
-- Generalized Anxiety Disorder
-- Gout
-- Major Depression

-- Multiple Sclerosis

-- Osteoporosis

-- Parkinson’s Disease

-- Psoriasis

-- Psoriatic Arthritis

-- Rheumatoid Arthritis: DMARDs

-- Schizophrenia

-- Type 2 Diabetes

-- Ulcerative Colitis


For each disease examined, the series provides product-oriented patient flow and line-of-therapy analysis among newly diagnosed patients in the United States. Quarterly data analysis also evaluates the overall drug-treated population to measure add-versus-switch patterns and brand share for key products.

About Decision Resources

Decision Resources ( is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources Group company.

About Decision Resources Group

Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

Decision Resources Group
Christopher Comfort, 781-993-2597

Source: Decision Resources